The European Commission has agreed to purchase an additional 15 million doses of an as yet unspecified Omicron-targeted vaccine booster candidate, while Australia is due to receive 15 million ‘variant-specific doses’ in 2022. Moderna has reportedly indicated it can provide 13 million doses to the UK by the end of the year, while it also recently entered an agreement with US authorities to supply 66 million doses of a different bivalent vaccine (mRNA-1273.222), which targets the BA.4 and BA.5 variants. Half of each vaccine dose (25 micrograms) is aimed at the original virus strain and the other half (25 micrograms) targets BA.1. ‘We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved COVID-19 vaccines and this will include the vaccine.’ What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve,’ she said. ‘The first generation of COVID-19 vaccines being used in the UK continue to provide important protection against the disease and save lives. MHRA CEO Dr June Raine said clinical trials indicate that the bivalent booster vaccine provides a ‘strong immune response’ against Omicron BA.1 as well as the original strain. The ‘bivalent’ vaccine (mRNA-1273.214), developed by Moderna, was approved for adult booster doses by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness. (Image: AAP)Ī dual vaccine designed to tackle the original COVID virus and the newer Omicron variant has been approved for use in the UK. Prime Minister Anthony Albanese and Victorian Premier Daniel Andrews at Monash University’s Clayton Campus after it was announced as the site for the new mRNA vaccine production facility. ![]() The approval comes in the same week that Monash University was selected to house the first mRNA production facility in the Southern Hemisphere.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |